Hua Medicine reported unaudited consolidated earnings results for the six months ended June 30, 2019. For the period, the company reported loss and total comprehensive expense for the period was RMB 235,500,000 compared to RMB 1,506,939,000 a year ago. Basic and diluted loss per share was RMB 0.25 compared to RMB 13.58 a year ago.